Your browser doesn't support javascript.
loading
The accelerated approval program for oncology drugs: celebrating more than 250,000 life-years gained and counting.
Patterson, Julie; O'Brien, John Michael; Campbell, Jonathan D.
Afiliação
  • Patterson J; National Pharmaceutical Council, 717 Pennsylvania Ave NW, Ste 800, Washington, DC 20006. Email: jpatterson@npcnow.org.
Am J Manag Care ; 30(8): e223-e225, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-39146478
ABSTRACT
This commentary explores how 2 recently published studies evaluating the clinical benefit of the FDA's accelerated approval program for oncology drugs came to different conclusions.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Aprovação de Drogas / Antineoplásicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Aprovação de Drogas / Antineoplásicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article